CMPS
COMPASS Pathways plc
NasdaqGSUSDEQUITY
DELAYED
Last price
13.41
▼ 0.41 (2.95%)
MARKET · —
Price
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
14.09
Prev close
13.82
Day high
14.02
Day low
13.30
Volume
1.93M
Market cap
—
P/E (TTM)
—
52W range
4.40 – 15.40
Trailing performance
Returnvs SPY
1W
-0.89%
+0.5%
1M
+13.83%
+10.1%
3M
+15.01%
+11.9%
6M
+65.59%
+54.5%
YTD
+93.19%
+80.9%
1Y
+226.72%
+206.7%
3Y
+47.29%
-26.9%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on CMPS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | — |
| Operating revenue | $0 | $0 | $0 | $0 | — |
| Research & development | $118.44M | $119.04M | $87.52M | $65.05M | -0.5% |
| Selling, general & admin | $60.60M | $59.17M | $49.40M | $45.35M | +2.4% |
| Total operating expense | $175.29M | $157.11M | $124.04M | $95.98M | +11.6% |
| Operating income | -$175.29M | -$157.11M | -$124.04M | -$95.98M | -11.6% |
| Net interest income | $2.67M | $3.79M | $2.42M | $0 | -29.7% |
| Pre-tax income | -$290.33M | -$153.53M | -$117.68M | -$91.10M | -89.1% |
| Tax provision | -$2.47M | $1.59M | $780.00K | $408.00K | -255.1% |
| Net income | -$287.86M | -$155.12M | -$118.46M | -$91.50M | -85.6% |
| Net income to common | -$287.86M | -$155.12M | -$118.46M | -$91.50M | -85.6% |
| Basic EPS | -3.08 | -2.30 | -2.32 | -2.16 | -33.9% |
| Diluted EPS | -3.08 | -2.30 | -2.32 | -2.16 | -33.9% |
| EBIT | -$285.82M | -$149.05M | -$115.48M | -$91.10M | -91.8% |
| EBITDA | -$285.60M | -$148.82M | -$115.24M | -$90.77M | -91.9% |
| Basic shares | 93.50M | 67.48M | 67.48M | 42.44M | +38.6% |
| Diluted shares | 93.50M | 67.48M | 67.48M | 42.44M | +38.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $149.61M | $165.08M | $220.20M | $143.21M | -9.4% |
| Cash & short-term investments | $149.61M | $165.08M | $220.20M | $143.21M | -9.4% |
| Total current assets | $191.49M | $201.29M | $261.30M | $191.65M | -4.9% |
| Property, plant & equipment | $3.42M | $2.01M | $4.73M | $2.62M | +70.7% |
| Total assets | $210.35M | $213.67M | $275.99M | $197.29M | -1.6% |
| Total current liabilities | $247.79M | $34.02M | $19.60M | $15.60M | +628.5% |
| Current debt | $17.52M | $5.51M | — | — | +217.8% |
| Long-term debt | $14.11M | $24.65M | $28.76M | — | -42.8% |
| Total debt | $35.03M | $32.19M | $33.05M | $1.93M | +8.8% |
| Total liabilities | $263.20M | $58.97M | $50.24M | $16.01M | +346.3% |
| Retained earnings | -$822.59M | -$534.73M | -$379.61M | -$261.15M | -53.8% |
| Shareholder equity | -$52.85M | $154.69M | $225.74M | $181.28M | -134.2% |
| Working capital | -$56.30M | $167.28M | $241.69M | $176.06M | -133.7% |
| Net tangible assets | -$52.85M | $154.69M | $225.74M | $181.28M | -134.2% |
| Shares issued | 96.09M | 68.55M | 61.94M | 42.63M | +40.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$287.86M | -$155.12M | -$118.46M | -$91.50M | — | -85.6% |
| Depreciation & amortisation | $216.00K | $233.00K | $242.00K | $330.00K | — | -7.3% |
| Stock-based compensation | $13.59M | $19.52M | $17.28M | $13.12M | — | -30.4% |
| Change in working capital | -$14.25M | $11.72M | $3.48M | -$30.67M | — | -221.5% |
| Operating cash flow | -$157.24M | -$119.19M | -$97.38M | -$105.45M | — | -31.9% |
| Capital expenditure | — | — | -$66.00K | -$596.00K | -$334.00K | — |
| Investing cash flow | — | $0 | -$64.00K | -$596.00K | -$334.00K | — |
| Financing cash flow | $140.71M | $63.82M | $173.83M | $1.04M | — | +120.5% |
| Free cash flow | -$157.24M | -$119.19M | -$97.44M | -$106.05M | — | -31.9% |
| End cash position | $149.99M | $165.47M | $220.64M | $143.38M | — | -9.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | $0 | — |
| Operating revenue | $0 | $0 | $0 | $0 | $0 | — |
| Research & development | $29.18M | $26.48M | $29.91M | $27.32M | $30.32M | +10.2% |
| Selling, general & admin | $23.20M | $16.42M | $16.05M | $13.21M | $12.61M | +41.2% |
| Total operating expense | $49.79M | $40.43M | $58.86M | $36.61M | $38.65M | +23.2% |
| Operating income | -$49.79M | -$40.43M | -$58.86M | -$36.61M | -$38.65M | -23.2% |
| Net interest income | $2.26M | $954.00K | $173.00K | $483.00K | $747.00K | +137.0% |
| Pre-tax income | -$253.46M | $91.19M | -$96.61M | -$137.95M | -$38.27M | -377.9% |
| Tax provision | $331.00K | -$11.00K | -$2.73M | -$230.00K | $137.00K | +3,109.1% |
| Net income | -$253.79M | $91.20M | -$93.88M | -$137.72M | -$38.40M | -378.3% |
| Net income to common | -$253.79M | $77.64M | -$93.88M | -$137.72M | -$38.40M | -426.9% |
| Basic EPS | -1.88 | 0.71 | -1.00 | -1.44 | -0.41 | -364.8% |
| Diluted EPS | -1.88 | -0.30 | -1.00 | -1.44 | -0.41 | -526.7% |
| EBIT | -$251.98M | $92.66M | -$95.47M | -$136.84M | -$37.12M | -372.0% |
| EBITDA | -$251.98M | $92.66M | -$95.47M | -$136.83M | -$36.96M | -372.0% |
| Basic shares | 135.04M | 110.06M | 93.64M | 95.34M | 93.34M | +22.7% |
| Diluted shares | 135.04M | 130.27M | 93.64M | 95.34M | 93.34M | +3.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $433.30M | $466.01M | $149.61M | $185.94M | $221.88M | — | -7.0% |
| Cash & short-term investments | $433.30M | $466.01M | $149.61M | $185.94M | $221.88M | — | -7.0% |
| Total current assets | $475.67M | $510.87M | $191.49M | $242.39M | $276.40M | — | -6.9% |
| Property, plant & equipment | $3.94M | $2.86M | $3.42M | $3.93M | $4.34M | — | +37.6% |
| Total assets | $504.56M | $531.74M | $210.35M | $255.61M | $293.54M | — | -5.1% |
| Total current liabilities | $367.29M | $153.80M | $247.79M | $197.45M | $31.33M | — | +138.8% |
| Current debt | — | — | $17.52M | $12.67M | $7.98M | $8.99M | — |
| Long-term debt | $50.73M | $50.48M | $14.11M | $18.60M | $22.95M | — | +0.5% |
| Total debt | $54.63M | $53.31M | $35.03M | $35.18M | $35.29M | — | +2.5% |
| Total liabilities | $420.03M | $205.05M | $263.20M | $218.02M | $130.98M | — | +104.8% |
| Retained earnings | -$985.19M | -$731.39M | -$822.59M | -$728.72M | -$591.00M | — | -34.7% |
| Shareholder equity | $84.53M | $326.69M | -$52.85M | $37.59M | $162.56M | — | -74.1% |
| Working capital | $108.39M | $357.07M | -$56.30M | $44.94M | $245.07M | — | -69.6% |
| Net tangible assets | $84.53M | $326.69M | -$52.85M | $37.59M | $162.56M | — | -74.1% |
| Shares issued | 134.95M | 134.92M | 96.09M | 96.00M | 93.59M | — | +0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$253.79M | $91.20M | -$93.88M | -$137.72M | -$38.40M | — | -378.3% |
| Depreciation & amortisation | $0 | $0 | $6.00K | $15.00K | $158.00K | — | — |
| Stock-based compensation | $4.03M | $2.90M | $2.85M | $3.21M | $3.60M | — | +39.1% |
| Change in working capital | $3.24M | -$11.26M | $13.88M | -$3.41M | -$7.08M | — | +128.7% |
| Operating cash flow | -$40.31M | -$47.94M | -$37.79M | -$35.11M | -$38.69M | — | +15.9% |
| Investing cash flow | — | — | — | — | — | $0 | — |
| Financing cash flow | $7.56M | $362.45M | $187.00K | $0 | $166.00K | — | -97.9% |
| Free cash flow | -$40.31M | -$47.94M | -$37.79M | -$35.11M | -$38.69M | — | +15.9% |
| End cash position | $433.72M | $466.39M | $149.99M | $186.32M | $222.26M | — | -7.0% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
13.63
-1.59% from price
SMA 20
12.80
+4.16% from price
SMA 50
12.80
+4.13% from price
SMA 100
11.08
+21.05% from price
SMA 200
8.75
+52.33% from price
EMA 12
13.42
-0.07% from price
EMA 26
13.04
+2.90% from price
EMA 50
12.52
+7.11% from price
RSI (14)
53.1
Neutral
MACD (12,26,9)
0.39
Hist 0.07
ATR (14)
0.77
5.76% of price
Realised vol 30D
66.4%
Annualised
Bollinger upper
15.10
20, 2σ
Bollinger lower
10.50
20, 2σ
50 / 200 cross
Golden
12.80 vs 8.75
Trend bias
Above 200
+52.33%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.54
More volatile than market
Correlation to SPY
0.22
Largely independent
Realised vol 30D
66.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-38.2%
Peak to trough
Max drawdown 5Y
-95.2%
Peak to trough
ATR 14
0.77
5.76% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Cybin Conference: Helus CEO Eyes Q4 Phase III Depression Data for HLP003
MarketBeat · 9d ago
COMPASS Pathways (CMPS) Q2 2026 Earnings Call Transcript
Motley Fool · 10d ago
Compass Pathways Targets 2027 COMP360 Launch as FDA Filing Advances
MarketBeat · 10d ago
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Market Exclusive · 13d ago
COMPASS Pathways (CMPS) Could Be 45% Below Fair Value On VA Trial Collaboration
Simply Wall St. · 15d ago
B. Riley Adjusts COMPASS Pathways Price Target to $22 From $17, Maintains Buy Rating
MT Newswires · 17d ago
RBC Adjusts PT on COMPASS Pathways to $21 From $22, Maintains Outperform Speculative Risk Rating
MT Newswires · 17d ago
Compass Pathways to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026
Business Wire · 17d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.